The anti-cancer and cancer treatment sector surges, Shou Tai Shen hits the daily limit

MaticHoleFiller · 2026-03-27T10:17:33+00:00

March 27 News, as of 14:35, the anti-cancer and cancer treatment sector surged significantly, with ShouTaiShen, XinLiTai, AoSaiKang, and ShuangLu Pharmaceutical hitting the daily limit. KeLong Pharmaceutical, HengRui Medicine, RuiZhi Medical, and BeiDa Pharmaceutical also saw notable gains.Disclaimer: The market carries risks; please invest cautiously. This article is automatically published based on third-party databases and does not represent Sina Finance's views. Any information appearing in this article is for reference only and does not constitute personal investment advice. For discrepancies, please refer to the official announcements. If you have questions, contact biz@staff.sina.com.cn.

MaticHoleFiller

2026-03-27 10:17:33

March 27 news, as of 14:35, the cancer treatment sector surged, with Shuttaishen, Xinlitai, Aosaikang, and Shuanglu Pharmaceutical hitting the daily limit, while Kelun Pharmaceutical, Hengrui Medicine, Ruizhiyiyuan, and Benda Pharmaceutical among others saw significant gains.

Disclaimer: The market has risks, and investment should be cautious. This article is automatically published based on a third-party database and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to actual announcements for any discrepancies. For inquiries, please contact biz@staff.sina.com.cn.

Massive information, precise interpretation, all in the Sina Finance APP

Editor: Xiaolang Express

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.